Mumbai, July 26 -- Roche Diagnostics GmbH of Mannheim, Germany received approval from Office of The Trade Marks Registry on the trademark ACCU-CHEK (939093).
The description of the mark registered is "Computer software and computer hardware for medical purpose, electronic data management systems in the medicinal sector." It comes under Class 9 Trademark classification.
Application for the trademark was filed on July 13, 2000.
The Trademark was published in Journal No. 1597 on July 15, 2013.
About the Company
Roche Diagnostics GmbH, a biotechnology company, develops bio-chemicals, enzymes, and technologies for diagnostics, life sciences, pharma/biotech, and OEM industries. It offers molecular diagnostics, diagnostic enzymes, in-vitro diagnostics, and tissue-based cancer diagnostics, as well as immunology tools for diagnostic applications; and offers bio-substances, including active ingredients for food-grade applications. The company also provides instruments and reagents for genome sequencing, microarray analysis, nucleic acid purification, real-time PCR, and cell analysis applications; medicines in oncology, virology, inflammation, metabolism, and CNS; diabetes management solutions; and cell biology, sample preparation, and sequencing solutions, as well as PCR assays, microarrays, and discovery reagents. In addition, it offers customized development and manufacturing services, as well as online technical support services. Roche Diagnostics was formerly known as Boehringer Mannheim GmbH and changed its name to Roche Diagnostics GmbH in January 1999. The company was founded in 1859 and is based in Mannheim, Germany. Roche Diagnostics GmbH operates as a subsidiary of Roche Holding AG. As of March 31, 1998, Roche Diagnostics GmbH operates as a subsidiary of Hoffmann-La Roche Inc.